A Study of DTaP//PRP-T Combined Vaccine (ACTACEL) Versus Local DTaP and Act-HIB Monovalent Vaccine in Healthy Infants

NCT01062477 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1056

Enrollment

INDUSTRY

Sponsor class

Conditions

Diphtheria
Tetanus
Pertussis
Haemophilus Influenzae Type B

Interventions

BIOLOGICAL: DTaP//PRP-T Combined Vaccine
BIOLOGICAL: DTaP//PRP-T Combined Vaccine
BIOLOGICAL: DTaP Combined Vaccine and PRP-Tetanus Conjugate Vaccine

Sponsor

Sanofi